In the morning of December 17, 2019, Professor Ming-Wei Wang (Director of the National Center for Drug Screening/Chinese National Compound Library (CNCL) and Dean of School of Pharmacy, Fudan University) met with Mr. Weiqiang Shen (General Manager, Shanghai Topgen Biopharmaceuticals, Co., Ltd.) at the second floor meeting room of CNCL. They discussed the opportunity of in-licensing three autoimmune disease prognosis prediction technologies from Cambridge, U.K. and associated market survey, clinical test and business model. An agreement was reached between them.